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Introduction: Sarcopenia is defined by a loss of muscle mass 
and strength. This study was performed to investigate the 
associations between muscle index (mass and strength) and 5-
year mortality or low physical performance. 
 
Methods: We included 396 subjects aged 65 years or older in 
the analysis. Muscle mass and fat mass were assessed by dual 
energy X-ray absorptiometry. Leg muscle strength and grip 
strength were measured using dynamometers. The 5-year 
mortality and low physical performance (Short Physical 
Performance Battery score < 9) were clinical outcome 
measures. Associations between muscle index and clinical 
outcomes were analyzed. Cox proportional hazard models for 
mortality and logistic regression models for low physical 
performance were built. 
 
Results: Leg muscle strength and grip strength were 
significantly associated with 5-year mortality and low physical 
performance in men and women. Total muscle mass and 
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appendicular skeletal mass in men and women and appendicular 
skeletal mass divided by height squared in men were associated 
with 5-year mortality. No association was found between 
muscle mass indices and 5-year low physical performance. Leg 
muscle strength was an independent predictor for low physical 
performance in men (OR = 0.971; 95% CI = 0.945-0.999; P = 
0.041) after adjustment for age, fat, cognition and depression. 
Grip strength was an independent predictor for mortality (HR = 
0.959; 95% CI = 0.928-0.991; P = 0.014) and low physical 
performance (OR = 0.950; 95% CI = 0.912-0.989; P = 0.012) 
in men after adjustment for age, fat, cognition and depression. 
 
Conclusions: Muscle strength is a better indicator for 5-year 
adverse clinical outcomes of mortality and low physical 
performance than muscle mass. In men, muscle strength is an 
independent predictor of 5-year adverse clinical outcome. 
------------------------------------- 
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 Sarcopenia is defined by a loss of muscle mass and 
strength with aging (1, 2). Sarcopenia is significantly 
associated with low physical performance, disability, 
hospitalizations, frailty and mortality (3-5). The muscle mass 
or strength (quality) related indices with various definitions 
have been considered as muscle indices. In the researches, 
sarcopenia has been conventionally defined by using only 
muscle mass index with different definitions (6) Several studies, 
however, have reported muscle strength declines faster than 
muscle mass in elderly, indicating the non-linear relationship 
between muscle mass and strength in old people (7, 8). 
Moreover, the age-associated loss of muscle strength is not 
completely explained by the loss of muscle mass (9, 10). 
Although there has been a conceptual definition for sarcopenia 
in terms of loss of muscle mass, the most appropriate muscle 
index for the definition of sarcopenia has not been agreed upon 
(2, 6, 11, 12).  
 From the clinical point of view, the proper indicator 
should be closely associated with clinical outcomes, and can 
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predict adverse outcomes such as functional limitation, 
disability and mortality. It is unclear which muscle index is the 
most reliable indicator for adverse clinical outcomes in elderly. 
A recent cross-sectional study with 1,705 elderly revealed 
that muscle strength is the single best measure of age-related 
muscle change (12). In our previous study, we found that 
muscle mass is not associated with physical performance in 
weak older adult, emphasizing muscle strength as a better index 
from a clinical perspective (13). Several longitudinal studies 
have reported that low muscle strength is predictive of 
functional limitation and physical disability in older people (14, 
15). To our knowledge, this is the first longitudinal study to 
investigate causal relationships of both muscle indices and 
adverse clinical outcomes with adjustment of possible 
covariates such as sex (16), obesity (17), cognition (18) and 
depression (19). 
 The present study, which was part of a prospective 
observational cohort study with 5-year follow-up, was 
conducted to investigate the relationship between muscle index 
and 5-year clinical outcomes in a population of community-
dwelling elderly, and to determine independent predictors for 
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adverse clinical outcomes after adjustment for potential 
confounders. We hypothesized that muscle strength would be a 
better predictor for clinical outcomes than muscle mass. The 




MATERIALS AND METHODS 
 
1. Study population 
 The analysis in this study was performed using data 
obtained during the Korean Longitudinal Study on Health and 
Aging (KLoSHA), a population-based prospective cohort study 
conducted on residents aged 65 years or older in Seongnam, 
South Korea. Seongnam is an urban area with a population 
composition similar to that of the South Korean population. A 
detailed description of the KLoSHA was published elsewhere 
(20). Briefly, a random sample of people aged 65 years or older 
was drawn among citizens of Seongnam, which had a total 
population of 931,019 in 2005, and 61,730 (6.6%) aged 65 
years or older. Finally, 1000 subjects (561 women, 439 men) 
agreed to participate in the study. All subjects were ethnic 
Koreans. The baseline examination was conducted from 
September 2005 to September 2006. A total of 560 people 
(274 women, 286 men) for whom all of the baseline 
anthropometric parameters, body composition, and muscle 
strength measurement data were available were included. 
Among 560 subjects, 41 subjects died, and 355 completed the 
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5-year follow-up examinations between May 2010 and March 
2012. The causes of drop-out were incomplete data (n = 22), 
and decline to follow-up (n = 142). All assessments were 
carried out at Seoul National University Bundang Hospital 
located in Seongnam. The study protocol was approved by the 
Institutional Review Board of Seoul National University 
Bundang Hospital. Informed consent was obtained from all of 
the participants. 
 
2. Demographic and anthropometric data 
 Trained and certified nurses, using standardized 
questionnaires, recorded age, gender, and comorbidities 
including hypertension, heart disease, stroke, parkinsonism, 
diabetes mellitus, cancer, chronic lung disease, arthritis and 
fracture. Regular exercise was defined as an exercise regimen 
of at least 30 min for 3 times or more per week. Physical 
activity levels were estimated by summing times spent walking, 
gardening, woodworking, lifting, or shoveling over a typical 24-
hour period. 
 Height and body weight were measured to the nearest 
0.1 cm or 0.1 kg, respectively, with subjects wearing light 
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garments. Body mass index was calculated as weight divided by 
height squared (kg/m2). Waist circumference was measured at 
the narrowest point between the lower limit of the rib cage and 
the iliac crest.  
 
3. Muscle mass index 
 Dual energy X-ray absorptiometry (DXA) is an efficient 
method for research and clinical use to estimate muscle mass 
with minimal radiation (2). Total muscle mass (total lean mass) 
was measured by DXA (Lunar Corporation, Madison, WI, USA). 
Appendicular skeletal muscle mass (ASM) was calculated as 
the sum of the muscle mass of the 4 extremities. We used ASM 
divided by weight (ASM/Wt), and by height squared (ASM/Ht2) 
as muscle mass indices (2).  
 
4. Muscle strength index 
 As muscle strength indices, isokinetic knee extensor 
strength and grip strength were measured. The isokinetic 
muscle strength of the right knee extensors was measured 
using an isokinetic dynamometer (Biodex Isokinetic Tester; 
Biodex Medical Systems, Shirley, NY, USA) at an angular 
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velocity of 60°/sec. Subjects performed two sets of 5 
repetitions, with a 30-sec rest between sets, by exerting 
maximum pressure on the arm of the isokinetic device. The 
concentric peak torque values (Nm) obtained from five torque-
angle curves in each set were used to evaluate the strength of 
knee extensors. Grip strength of right hand was measured with 
a hand dynamometer (Hand Evaluation Kit; Sammons Preston, 
Bolingbrook, IL, USA). 
 
5. Evaluation of clinical outcomes  
 The study outcomes were 5-year all-cause mortality 
and low physical performance. All-cause mortality data over 
the 5-year period were obtained from the Ministry of Public 
Administration and Security national database. Follow-up 
duration was obtained from the difference between the date of 
baseline visit and the date of death or the end date of the 
follow-up. To evaluate physical performance, the Short 
Physical Performance Battery (SPPB) was evaluated at the 5-
year follow-up visit. The SPPB is a standard functional 
outcome measure both for research and clinical outcomes (21). 
A total possible score of 12 was created using the sum of 4 
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possible points for 3 tests of chair stands, gait speed, and 
standing balance. Subjects were first asked to balance in a 
standing position with their feet side by side, semi-tandem, and 
fully tandem for 10 sec each. Subjects were next asked to walk 
a distance of 4 m as fast as possible. Finally, subjects were 
asked to stand from a sitting position in a chair and return to 
the seated position five times as quickly as possible while 
keeping their arms folded across their chest. Low physical 




 We included fat mass, cognitive and depressive 
evaluations as covariates among the broad range of geriatric 
evaluations performed in KLoSHA (20) as potential 
confounders. Total fat mass was measure by DXA. Percentage 
fat mass was calculated as total fat massⅹ100/body weight. 
Assessment of cognition was done using the validated mini-
mental state examination (MMSE) of the Korean version of the 
CERAD-K assessment packet (23). The MMSE consists of 30 
questions that assess orientation, attention, immediate- and 
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short-term recall, language function, and the ability to follow 
simple verbal and written commands. MMSE scores range from 
0 to 30 with a higher score indicating better global cognition. 
Severity of depression was evaluated using the Korean version 
of the geriatric depression scale (GDS) (24). The GDS is a 
questionnaire in which participants are asked to respond to the 
30 questions by answering yes or no. GDS scores range from 0 
to 30 with a higher score indicating more depressive state. 
 
7. Statistical analysis 
 Statistical significance for the differences between the 
subjects with different clinical outcomes were assessed using 
an independent t-test or Mann-Whitney U test for continuous 
variables and Pearson’s chi-square test or Fisher’s exact test 
for categorical variables, as appropriate. Spearman’s rho 
correlation between each variable was tested before the 
multivariate analyses. Significant variables from the univariate 
analyses and possible covariates were included in the final 
multivariate models. Adjusted Cox proportional hazard models 
were employed to evaluate the relationships between muscle 
index and mortality. To identify the independent predictors for 
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low physical performance, a multivariate logistic regression 
analysis was performed. All tests were two-sided and a P 
value less than 0.05 were taken as statistically significant. The 
PASW statistics version 18.0 (SPSS Inc., IBM Corporation, 






1. Study participants 
 Among 560 subjects who performed all of the baseline 
evaluations, 355 subjects (171 women, 184 men) completed 
the 5-year follow-up examination. During 5 years, 41 subjects 
(7.3%) of the cohort died. The 205 subjects who did not 
complete 5-year follow-up examination were older (P < 
0.001), and had lower body weight (P = 0.048), higher waist to 
hip ratio (P = 0.003), lower total muscle mass (P = 0.035), 
lower ASM (P = 0.020), lower leg muscle strength (P < 0.001), 
lower grip strength (P < 0.001), lower MMSE (P < 0.001), and 
higher GDS (P < 0.001). 
 The correlations between baseline muscle mass and 
muscle strength in each gender were shown in Fig. 1. Men 
showed stronger linear correlation than women (R2 = 0.06 in 
women; R2 = 0.152 in men).  
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2. Baseline factors associated with mortality 
 Table 1 shows the characteristics of the subjects alive 
and dead. Subjects who died were significantly older (P < 0.001 
in women; P < 0.001 in men), and had lower total muscle mass 
(P = 0.028 in women; P = 0.027 in men), lower ASM (P = 
0.004 in women; P = 0.010 in men), lower leg muscle strength 
(P = 0.001 in women; P < 0.001 in men), lower grip strength 
(P < 0.001 in women, P < 0.001 in men), and lower MMSE 
scores (P = 0.001 in women; P = 0.001 in men) in both men 
and women. In women, no regular exercise (P = 0.032), lower 
body weight (P = 0.016), lower body mass index (P = 0.048), 
lower fat mass (P = 0.002), lower percentage body fat (P = 
0.029) were significantly associated with 5-year mortality. In 
men, higher serum cholesterol level (P < 0.001), lower 
ASM/Ht2 (P = 0.036) and higher GDS scores (P = 0.014) were 
significantly associated with 5-year mortality.  
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Table 1. Characteristics of the subjects alive and dead 
 Women (n = 186)  Men (n = 210) 
Alive (n = 171) Dead (n = 15) P value  Alive (n = 184) Dead (n = 26) P value 
Age (yr) 70.94±5.43 79.47±8.73 < 0.001  72.10±6.66 79.35±9.19 < 0.001 
No regular exercise 86 (51.2) 12 (80.0) 0.032  58 (31.5) 11 (42.3) 0.273 
Physical activity (hours) 3.94±1.56 3.73±1.52 0.630  4.32±1.89 3.84±1.64 0.254 
Serum cholesterol (mg/dL) 199.85±35.15 198.36±34.26 0.878  196.62±34.53 221.96±27.85 <0.001 
Serum albumin (g/dL) 4.03±0.27 4.01±0.20 0.512  4.09±0.27 4.05±0.31 0.790 
Serum triglycerides (mg/dL) 124.78±54.82 159.86±84.29 0.066  130.13±73.45 154.42±97.05 0.054 
Serum hsCRP (mg/dL) 0.27±0.73 0.20±0.26 0.807  0.26±0.76 0.30±0.66 0.931 
Comorbidities        
   Hypertension 78 (45.9) 9 (60.0) 0.294  76 (41.3) 15 (57.7) 0.114 
   Heart disease 29 (17.1) 6 (40.0) 0.041  21 (11.4) 4 (15.4) 0.524 
   Stroke or Parkinsonism 5 (2.9) 2 (13.3) 0.102  7 (3.8) 3 (11.5) 0.112 
   Diabetes mellitus 28 (16.5) 1 (6.7) 0.473  30 (16.3) 9 (34.6) 0.033 
   Cancer 15 (8.8) 1 (6.7) 1.000  15 (8.2) 4 (15.4) 0.266 
   Chronic lung disease 16 (9.4) 2 (13.3) 0.644  17 (9.2) 3 (11.5) 0.720 
   Arthritis 95 (55.9) 7 (46.7) 0.491  36 (19.6) 6 (23.1) 0.675 
   Fracture 30 (17.6) 3 (20.0) 0.734  25 (13.6) 4 (15.4) 0.764 
Weight (Kg) 57.06±7.77 51.02±11.22 0.016  66.23±9.445 63.90±11.44 0.271 
Body mass index (Kg/m2) 24.63±2.95 22.77±3.76 0.048  24.32±3.16 23.90±3.74 0.544 
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Waist circumference (cm) 84.73±9.28 84.18±12.91 0.879  87.67±8.61 89.57±8.79 0.319 
Waist to hip ratio 0.91±0.10 0.90±0.08 0.734  0.92±0.07 0.95±0.06 0.102 
Total muscle mass (kg) 34.27±3.57 32.14±3.47 0.028  47.40±5.29 44.91±5.75 0.027 
ASM (kg) 13.85±1.77 12.51±1.56 0.004  20.32±2.73 18.81±3.02 0.010 
ASM/Wt (%) 24.47±2.46 25.07±3.06 0.373  30.87±2.99 29.83±3.83 0.195 
ASM/Ht2 (Kg/m
2
) 5.99±0.61 5.81±0.59 0.255  7.45±0.85 7.08±0.87 0.036 
Total fat mass (kg) 19.83±5.50 15.08±7.00 0.002  15.83±6.08 15.67±6.86 0.904 
Percentage fat mass (%) 36.09±6.01 31.53±8.72 0.029  24.29±6.77 24.90±7.43 0.673 
Leg muscle strength (Nm) 51.80±16.02 37.32±15.34 0.001  84.59±24.30 61.33±27.16 < 0.001 
Grip strength (lbf) 31.52±12.54 19.27±13.84 < 0.001  58.24±17.85 42.54±15.35 < 0.001 
MMSE (points) 24.30±3.49 19.20±5.87 0.001  26.35±2.50 23.50±5.78 0.001 
GDS (points) 11.51±7.10 13.29±6.82 0.425  8.00±6.26 11.60±7.23 0.014 
Values are means ± SD or n (%), as appropriate. CRP, C-reactive protein; ASM, Appendicular skeletal mass; 
ASM/Wt, Appendicular skeletal mass divided by weight; ASM/Ht2, Appendicular skeletal mass divided by height 




3. Baseline factors associated with low physical 
performance 
 The characteristics of subjects with high physical 
performance (SPPB ≥ 9) and with low physical performance 
(SPPB < 9) are presented in Table 2. Older age (P < 0.001 in 
women; P < 0.001 in men), lower leg muscle strength (P < 
0.001 in women; P < 0.001 in men), and lower grip strength (P 
= 0.040 in women; P < 0.001 in men) were associated with 
lower physical performance after 5 years in both gender. No 
regular exercise (P = 0.012), higher waist circumference (P = 
0.014), lower MMSE (P < 0.001), higher GDS (P < 0.001) were 




Table 2. Characteristics of the subjects with high performance and with low performance 
 Women (n = 171)  Men (n = 184) 
High 
performance  
(n = 130) 
Low 
performance 
(n = 41) 
P value  High 
performance  
(n = 162) 
Low 
performance 
(n = 22) 
P value 
Age (yr) 70.70±5.35 75.43±7.80 < 0.001  71.22±5.79 78.55±8.97 < 0.001 
No regular exercise 58 (45.7) 28 (68.3) 0.012  51 (31.5) 7 (31.8) 0.975 
Physical activity (hours) 4.07±1.55 3.52±1.53 0.051  4.41±1.92 3.68±1.52 0.089 
Serum cholesterol (mg/dL) 198.76±35.66 203.40±33.64 0.467  196.76±34.50 195.64±35.54 0.887 
Serum albumin (g/dL) 4.02±0.28 4.08±0.24 0.258  4.09±0.27 4.14±0.28 0.364 
Serum triglycerides (mg/dL) 126.14±57.98 120.35±43.30 0.830  128.76±74.18 140.05±68.65 0.248 
Serum hsCRP (mg/dL) 0.26±0.49 0.33±1.21 0.183  0.28±0.81 0.09±0.10 0.327 
Comorbidities        
   Hypertension 61 (47.3) 17 (41.5) 0.514  68 (42.0) 8 (36.4) 0.616 
   Heart disease 25 (19.4) 4 (9.8) 0.154  19 (11.7) 2 (9.1) 1.000 
   Stroke or Parkinsonism 1 (0.8) 4 (9.8) 0.012  6 (3.7) 1 (4.5) 0.596 
   Diabetes mellitus 19 (14.7) 9 (22.0) 0.277  25 (15.4) 5 (22.7) 0.366 
   Cancer 13 (10.1) 2 (4.9) 0.527  13 (8.0) 2 (9.1) 0.696 
   Chronic lung disease 14 (10.9) 2 (4.9) 0.363  14 (8.6) 3 (13.6) 0.434 
   Arthritis 70 (54.3) 25 (61.0) 0.451  28 (17.3) 8 (36.4) 0.045 
   Fracture 19 (14.7) 11 (26.8) 0.077  23 (14.2) 2 (9.1) 0.743 
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Weight (Kg) 56.87±7.51 57.64±8.60 0.583  66.37±9.12 65.18±11.91 0.589 
Body mass index (Kg/m2) 24.45±2.96 25.18±2.87 0.169  24.40±3.03 23.70±4.07 0.455 
Waist circumference (cm) 83.78±9.21 87.84±8.97 0.014  87.46±8.38 89.09±10.10 0.431 
Waist to hip ratio 0.90±0.10 0.94±0.12 0.102  0.92±0.07 0.94±0.06 0.133 
Total muscle mass (kg) 34.33±3.67 34.08±3.28 0.700  47.55±5.10 46.30±6.55 0.299 
ASM (kg) 13.92±1.78 13.63±1.78 0.376  20.39±2.61 19.80±3.54 0.463 
ASM/Wt (%) 24.66±2.40 23.87±2.58 0.074  30.93±2.81 30.41±4.16 0.573 
ASM/Ht2 (Kg/m2) 6.00±0.62 5.96±0.60 0.699  7.49±0.80 7.17±1.10 0.202 
Total fat mass (kg) 19.54±5.35 20.77±5.94 0.212  15.76±5.72 16.31±8.40 0.770 
Percentage fat mass (%) 35.73±5.97 37.23±6.09 0.164  24.23±6.40 24.74±9.25 0.803 
Leg muscle strength (Nm) 54.52±15.32 43.15±15.29 < 0.001  87.20±23.62 66.01±21.16 < 0.001 
Grip strength (lbf) 32.64±12.82 28.02±11.04 0.040  60.24±17.25 43.50±15.33 < 0.001 
MMSE (points) 25.04±3.03 21.98±3.83 < 0.001  26.50±2.38 25.23±3.05 0.051 
GDS (points) 10.30±3.58 15.32±7.41 < 0.001  7.77±6.01 9.68±7.82 0.403 
Values are means ± SD or n (%), as appropriate. ASM, Appendicular skeletal mass; ASM/Wt, Appendicular skeletal 
mass divided by weight; ASM/Ht2, Appendicular skeletal mass divided by height squared; MMSE, Mini-Mental 
Status Examination; GDS, Geriatric depression scale. 
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4. Independent predictors of mortality 
 The Cox regression models to identify mortality risks 
for muscle indices are shown in Table 3. For each of muscle 
strength index, leg muscle and grip strength, separate model 
was constructed (Model 1 and 2). Because strong correlations 
were found between total muscle mass, ASM, and ASM/Ht2 
(Spearman ρ = 0.685 to 0.960), only ASM/Ht2 was included in 
the final model as muscle mass index. ASM/Wt was also not 
included in the model because of moderate to strong correlation 
with fat index such as total fat mass and percentage fat mass 
(Spearman ρ = -0.626 to -0.758). All models were adjusted 
for age, percentage fat mass, MMSE and GDS. In women, 
regular exercise was included in model, and serum cholesterol 
level was included in men.  
 In women, there was no relationship between muscle 
indices and mortality risk. In men, the subjects with lower grip 
strength showed a higher risk of death (HR = 0.959; 95% CI = 
0.928-0.991; P = 0.014) after adjusting for age, percentage fat 
mass, MMSE, GDS and serum cholesterol. Muscle mass index, 




5. Independent predictors of low physical performance 
 The logistic regression models to identify independent 
predictors for low physical performance are shown in Table 3. 
As with Cox regression models for mortality, separate models 
were constructed for each of muscle strength index (Model 1 
and 2). Considering strong correlations between muscle mass 
indices (Spearman ρ = 0.705 to 0.956), only ASM/Ht2 was 
included in the final model. ASM/Wt was also not included in the 
model because of moderate to strong correlation with fat index 
(Spearman ρ = -0.614 to -0.772). All models were adjusted 
for age, percentage fat mass, MMSE and GDS. The models of 
women were additionally adjusted for regular exercise.  
 In women, both of muscle strength and mass indices 
were not independent predictors for low physical performance 
in 5 years adjusting for covariates. In men, lower leg muscle 
strength (OR = 0.971; 95% CI = 0.945-0.999; P = 0.041) and 
grip strength (OR = 0.950; 95% CI = 0.912-0.989; P = 0.012) 
were independent predictors for low physical performance after 
adjustment for covariates. Muscle mass index, ASM/Ht2, was 




Table 3. Predictors for adverse clinical outcomes of mortality and low physical performance 
 Women  Men 
 HR or OR (95% CI)*  P value  HR or OR (95% CI)* P value 
Predictors of mortality, Model 1 (Leg muscle strength) 
   Leg muscle strength 0.995 (0.947-1.046) 0.856  0.986 (0.965-1.007) 0.189 
   ASM/Ht2 0.595 (0.225-1.573) 0.295  0.928 (0.543-1.584) 0.784 
   Age 1.072 (0.984-1.169) 0.111  1.055 (0.998-1.115) 0.060 
   Percentage fat mass 0.918 (0.844-0.999) 0.048  1.012 (0.957-1.070) 0.678 
   MMSE 0.859 (0.733-1.005) 0.058  0.933 (0.832-1.047) 0.239 
   GDS 1.015 (0.915-1.127) 0.772  1.060 (0.997-1.127) 0.063 
Regular exercise 0.593 (0.103-3.405) 0.558  NA  
Serum cholesterol NA   1.013 (1.000-1.027) 0.043 
Predictors of mortality, Model 2 (Grip strength) 
   Grip strength 0.986 (0.935-1.041) 0.615  0.959 (0.928-0.991) 0.014 
   ASM/Ht2 0.608 (0.239-1.548) 0.297  0.890 (0.550-1.440) 0.634 
   Age 1.066 (0.978-1.162) 0.149  1.031 (0.974-1.091) 0.293 
   Percentage fat mass 0.913 (0.841-0.991) 0.029  0.993 (0.942-1.047) 0.803 
   MMSE 0.867 (0.742-1.012) 0.071  0.968 (0.876-1.070) 0.528 
   GDS 1.019 (0.924-1.124) 0.708  1.081 (1.020-1.147) 0.009 
Regular exercise 0.955 (0.200-4.563) 0.954  NA  




Predictors of low performance, Model 1 (Leg muscle strength) 
   Leg muscle strength 0.968 (0.937-1.000) 0.053  0.971 (0.945-0.999) 0.041 
   ASM/Ht2 1.118 (0.524-2.386) 0.772  1.004 (0.521-1.936) 0.989 
   Age 1.082 (1.000-1.171) 0.050  1.103 (1.029-1.183) 0.005 
   Percentage fat mass 1.060 (0.988-1.138) 0.105  1.028 (0.963-1.097) 0.413 
   MMSE 0.871 (0.762-0.995) 0.043  0.980 (0.797-1.206) 0.851 
   GDS 1.089 (1.022-1.159) 0.008  1.042 (0.966-1.124) 0.285 
Regular exercise 0.720 (0.303-1.713) 0.458  NA  
Predictors of low performance, Model 2 (Grip strength) 
   Grip strength 0.998 (0.963-1.036) 0.933  0.950 (0.912-0.989) 0.012 
   ASM/Ht2 0.929 (0.439-1.966) 0.847  0.956 (0.521-1.754) 0.884 
   Age 1.095 (1.010-1.187) 0.028  1.083 (1.012-1.159) 0.021 
   Percentage fat mass 1.051 (0.980-1.126) 0.162  1.024 (0.959-1.093) 0.481 
   MMSE 0.830 (0.726-0.948) 0.006  0.930 (0.768-1.127) 0.461 
   GDS 1.089 (1.024-1.158) 0.007  1.053 (0.976-1.135) 0.180 
Regular exercise 0.767 (0.325-1.808) 0.545  NA  
* HR for predictors of mortality or OR for predictors of low performance; ASM/Ht2, Appendicular skeletal mass 





 The results of the current study suggest that muscle 
strength index is a better indicator of 5-year adverse clinical 
outcomes than a muscle mass index. Muscle strength indices 
were more closely associated with 5-year mortality and low 
physical performance than muscle mass indices. Muscle mass 
indices were not independent predictors for 5-year clinical 
outcomes in both genders. In men, muscle strength indices 
were independent predictors for 5-year clinical outcomes after 
adjustment for muscle mass, age, fat, cognition, and depression. 
In women, muscle strength indices were not independent 
predictors for 5-year clinical outcomes. 
 Several studies have indicated that muscle strength is 
associated with mobility decline (25), physical performance (12, 
26, 27). Most of these evidences, however, were the results of 
cross-sectional analysis. Therefore, the causal relationship 
between muscle strength and clinical outcomes have been 
undisclosed. Our longitudinal study showed that muscle 
strength, evaluated by isokinetic knee extensor strength and 
grip strength, was significantly associated with 5-year 
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mortality and low physical performance of both men and women 
in univariate analyses. After the adjustment for potential 
confounders, muscle strength was an independent predictor for 
5-year clinical outcomes in men  
 Multiple definitions of muscle mass are used across 
studies (6). There is still controversy regarding the most 
proper muscle mass index according to the outcome measures 
(2, 16, 28). Among these definitions, we assessed total muscle 
mass, ASM, ASM/Wt, ASM/Ht2. Our study showed that total 
muscle mass and ASM were associated with 5-year mortality. 
ASM/Ht2 was correlated with 5-year mortality only in men. No 
association was found between muscle mass index and 5-year 
physical performance. The muscle mass index was not an 
independent predictor for mortality and low physical 
performance. 
Our results demonstrate that the muscle strength 
indices are better indicators of mortality and physical function 
than muscle mass indices. Based on these results, the 
alogorithm for sarcopenia case finding suggested by European 
Working Group on Sarcopenia should be modified (2). In this 
algorithm, sarcopenia is excluded if the muscle mass is normal 
25 
 
in an older subject with slow gait speed (≤ 0.8m/s). Our 
findings suggest that muscle strength should be measured 
instead of muscle mass to find a clinically meaningful 
sarcopenic subject. 
In the current study, each gender showed a series of 
different relationships between body composition data including 
muscle indices and clinical outcomes. Many previous studies 
regarding sarcopenia and body composition have employed 
stratified analysis by gender (6, 16, 27). Non-linear correlation 
between muscle mass and muscle strength in women (shown in 
Fig. 1) partially explains the poorer association between muscle 
mass indices and clinical outcomes in women. Considering that 
both of muscle mass and strength were not longitudinally 
associated with clinical outcomes in women, another index 
beyond muscle mass or strength is necessary in older women. 
 A few study reported that physical activity was 
associated with physical mobility decline and mortality in older 
persons (25, 29). The proportions of the subjects who did not 
exercise regularly were higher in 5-year mortality group and 
low physical performance group in women. In men, however, 
this association was not found. Although regular exercise was 
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not an independent predictor for clinical outcomes, clinicians 
may recommend regular exercise in elderly women. Because 
we used only a simple questionnaire to assess regular exercise, 
future studies with more objective measure of physical activity 
should be performed to unravel the exact association between 
physical activity, exercise and clinical outcomes. 
 The associations between high fat index and low 
physical performance have been suggested mostly in women 
(17, 30, 31). In current study, however, low total fat mass and 
percentage fat mass were associated 5-year mortality in 
women. We found no association between fat index and low 
physical performance. A cross-sectional study using the same 
cohort with ours reported similar results of no association 
between fat index and low physical performance (16). These 
inconsistent results across each study might be due to variable 
definition of fat index. Whereas we used fat index with a 
continuous variable as one of covariates, most of the studies 
categorized the fat index into a discrete variable. In addition, a 
study reported ethnic difference of fat infiltration between black 
and white (30). Therefore, ethnicity may be a possible 
confounder for these inconsistent associations across studies. 
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 Previous studies have demonstrated that cognitive 
impairment and depression are associated with low physical 
performance (18, 19). In the current study, cognitive 
impairment, evaluated by MMSE, was associated with mortality 
in both genders, and with low physical performance in women. 
Depressive state was significantly associated with 5-year 
mortality in men, and with low physical performance in women. 
A prospective cohort study reported that depressive symptoms 
were predictive of greater decline in physical performance (19). 
Although the stratified analysis according to gender was not 
performed in this study, our study showed a similar result in 
women. In the multivariate models, depression was an 
independent predictor for mortality in men, and for low physical 
performance in women. Cognitive impairment was an 
independent predictor for low performance in women. 
Therefore, screening and proper management of these 
symptoms may be important to prevent death and functional 
decline.  
The present study has certain limitations. A large 
number of subjects were lost to follow-up. There were 
significant differences in the baseline factors between the 
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subjects who followed through and those who dropped out. The 
poorer baseline scores for those who dropped out may have 
caused a healthy survivor bias effect on the results of this 
study. Because we employed stratified analysis according to the 
gender, the number of subjects was further decreased in each 
subgroup. In addition, we did not classify the study subjects 
according to the definitions of sarcopenia or obesity. The 
categorization of subjects may provide another glimpse of the 
complex relationships between body composition and clinical 
outcomes. 
 In conclusion, muscle strength is a better indicator of 
5-year mortality and low physical performance than muscle 
mass. Muscle strength was significantly associated with 5-year 
clinical outcomes in both genders. In men, most importantly, 
muscle strength was an independent predictor of 5-year 
clinical outcomes. Future researches should define sarcopenia 
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국   
 
: 근감소증  근 량과 근  감소  다. 본 연구는 근
 연  지  (근 량 및 근 )  5  후 사망 및 신체 실행 능 
하   조사하  해 시행 었다. 
 
방법: 65  이상 396 명  상  하여 연구를 시행하 다. 근
량과 지방량  이 에 지 방사  계 법(dual energy X-ray 
absorptiometry)  사용하여 평가하 다. 하지 근 과 악  역량
계(dynamometer)를 사용하여 하 다. 5  후 사망과 신체 실
행 능 하 (간편신체 행검사, Short Physical Performance 
Battery < 9)를 임상  결과   하 다. 근  연  지
 임상  결과 사이  연  분 하 다. 사망에 한 콕스 
 험 모  (Cox proportional hazard model)과 신체 실행 능 




남  모 에  하지 근 과 악  5  후 사망 및 신체 실행 능 
하  한 연 이 있었다. 여 과 남 에  근 량과 
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사지골격 근 량 (appendicular skeletal mass) 및 남 에  
사지골격 근 량  키  곱  나  지 는 5  후 사망과 
연 어 있었다. 근 량 연  지  5  후 신체 실행 능 하 
사이에는 연 이 발견 지 않았다. 하지 근  남 에  나이, 
지방량, 인지, 우울증  보 한 이후에도 신체 실행 능 하 (OR = 
0.971; 95% CI = 0.945-0.999; P =0.041)에 한 독립 인  
인자 다. 악  남 에  나이, 지방량, 인지, 우울증  보 한 
후에도 사망 (HR = 0.959; 95% CI = 0.928-0.991; P = 
0.014)과 신체 실행 능 하 (OR = 0.950; 95% CI = 0.912-
0.989; P = 0.012)  독립   인자 다.  
결 : 근  근 량보다 5  후 사망 및 신체 실행 능 하   
큰 연  보이는 지 이다. 남 에 는 근 이 5  후 사망 및 신
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